Drugs Made In America Acquisition Corp
DMAAU10.550USD
0.0000.00%
收盤 02/03, 16:00（美東）報價延遲15分鐘
0.00總市值
--本益比TTM
關於 Drugs Made In America Acquisition Corp 公司
Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition Corp簡介
公司代碼DMAAU
公司名稱Drugs Made In America Acquisition Corp
上市日期Jan 28, 2025
CEOStockwell (Lynn)
員工數量- -
證券類型Unit
年結日- -
公司地址1 East Broward Boulevard
城市FT LAUDERDALE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編33301
電話19548703099
網址
公司代碼DMAAU
上市日期Jan 28, 2025
CEOStockwell (Lynn)
Drugs Made In America Acquisition Corp公司高管
名稱
名稱/職務
職務
持股
持股變動
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
收入明細
由於公司未披露，未能獲取相關數據
由於公司未披露，未能獲取相關數據
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Drugs Made In America Acquisition LLC
17.88%
Kryger Capital Limited
1.28%
Wolverine Asset Management, LLC
0.55%
RiverNorth Capital Management LLC
0.44%
Clear Street Group Inc
0.20%
其他
79.65%
持股股東
持股股東
佔比
Drugs Made In America Acquisition LLC
17.88%
Kryger Capital Limited
1.28%
Wolverine Asset Management, LLC
0.55%
RiverNorth Capital Management LLC
0.44%
Clear Street Group Inc
0.20%
其他
79.65%
股東類型
持股股東
佔比
Corporation
17.88%
Investment Advisor
1.52%
Hedge Fund
0.61%
Investment Advisor/Hedge Fund
0.56%
Research Firm
0.20%
其他
79.24%
機構持股
更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
21
706.12K
14.40%
--
2025Q3
21
706.12K
14.40%
-280.00K
2025Q2
19
986.13K
14.72%
-2.41M
2025Q1
19
3.40M
0.80%
+3.21M
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Drugs Made In America Acquisition LLC
4.19M
17.88%
+4.19M
--
Feb 18, 2025
Kryger Capital Limited
300.00K
1.28%
+300.00K
--
Sep 30, 2025
Wolverine Asset Management, LLC
130.00K
0.55%
--
--
Sep 30, 2025
RiverNorth Capital Management LLC
102.37K
0.44%
-318.13K
-75.65%
Sep 30, 2025
Clear Street Group Inc
47.48K
0.2%
+47.48K
--
Sep 30, 2025
Clear Street LLC
45.92K
0.2%
+40.07K
+685.09%
Jun 30, 2025
Robinson Capital Management, LLC
30.00K
0.13%
--
--
Sep 30, 2025
Citadel Advisors LLC
11.96K
0.05%
-2.06K
-14.70%
Sep 30, 2025
UBS Financial Services, Inc.
18.39K
0.08%
--
--
Sep 30, 2025
Heights Capital Management, Inc.
--
0%
-650.00K
-100.00%
Jun 30, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
CrossingBridge Pre-Merger SPAC ETF
0%
SPAC and New Issue ETF
0%
RiverNorth Enhanced Pre-Merger SPAC ETF
0%
CrossingBridge Pre-Merger SPAC ETF
佔比0%
SPAC and New Issue ETF
佔比0%
RiverNorth Enhanced Pre-Merger SPAC ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
